The session led by Will Hind, Founder and CEO, Alpharmaxim, will cover the theory of behavioural science, provide examples from other industries, describe a research project utilising behavioural science in Parkinson’s disease, explain how behavioural science can be incorporated into planning and how it will increase the effectiveness and efficiency of your communications.